Companies: 10,795·Total market cap: $144.5T
COSMOS Pharmaceutical Corporation

COSMOS Pharmaceutical Corporation

CSMYFOTCHealthcare● Active
$41.20
+$4.14(+11.17%)
Market Cap$3.3B
P/E Ratio—
52W High$48.271
52W Low$37.06
Overview

COSMOS Pharmaceutical Corporation (CSMYF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CSMYF · cash on hand · updated May 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$57.04B▲ +9.1% vs prior year
FY · as of May 31, 2025 · Reported in JPY
Cash & Cash Equiv. (CCE)
$57.04B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+9.1%
vs prior fiscal year
Latest Quarter
$30.97B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in JPY

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: May 31, 2025

Net cash vs debt

Cash & ST Investments$57.04BCash on Hand
Total Debt$49.96BTotal Debt
Net Cash / Net Debt+$7.08BNet Cash Position
Cash vs Debt Ratio
Cash 53%Debt 47%

COSMOS Pharmaceutical Corporation has a net cash position of $7.08B, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$57.04B − $49.96B = +$7.08B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CSMYF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
May 31, 2025Latest$57.04B+9.1%
May 31, 2024$52.30B+13.9%
May 31, 2023$45.93B+22.9%
May 31, 2022$37.36B-32.2%
May 31, 2021$55.11B+5.7%
CSMYF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical CorporationYOU
CSMYF
$57.04B1746.7%
#2
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#3
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

COSMOS Pharmaceutical Corporation (CSMYF) cash on hand as of May 31, 2025 is $57.04B, comprising $57.04B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as COSMOS Pharmaceutical Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as COSMOS Pharmaceutical Corporation cash reserves or cash position.

COSMOS Pharmaceutical Corporation annual cash on hand history shows increased +9.1% in 2025: increased +9.1% in 2025. COSMOS Pharmaceutical Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

COSMOS Pharmaceutical Corporation carries total debt of $49.96B against cash of $57.04B, resulting in a net cash position of +$7.08B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

CSMYF cash on hand · 5 questions

As of May 31, 2025, COSMOS Pharmaceutical Corporation (CSMYF) has $57.04B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $57.04B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (February 28, 2026): $30.97B. Data sourced from the annual 10-K filing via FMP.

CSMYF cash on handCSMYF cash reservesCSMYF cash 2025how much cash does CSMYF have

▸ Source: FMP /balance-sheet-statement · US GAAP · COSMOS Pharmaceutical Corporation · COSMOS Pharmaceutical Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: May 31, 2025